Paradoxical regulation of estrogen-dependent growth factor gene expression in estrogen receptor (ER)-negative human breast cancer cells stably expressing ER
- 1 July 1994
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 82 (2), 123-128
- https://doi.org/10.1016/0304-3835(94)90001-9
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- A current view of tamoxifen for the treatment and prevention of breast cancerBritish Journal of Pharmacology, 1993
- Estrogenic actions of RU486 in hormone-responsive MCF-7 human breast cancer cellsEndocrinology, 1993
- Growth Stimulation and Differential Regulation of Transforming Growth Factor-β1 (TGFβ1), TGFβ2, and TGFβ3 Messenger RNA Levels by Norethindrone in MCF-7 Human Breast Cancer CellsMolecular Endocrinology, 1991
- Endocrine Pharmacology of Antiestrogens as Antitumor Agents*Endocrine Reviews, 1990
- Steroid Receptor Family: Structure and FunctionsEndocrine Reviews, 1990
- Expression of Transforming Growth Factor α and its Messenger Ribonucleic Acid in Human Breast Cancer: Its Regulation by Estrogen and its Possible Functional SignificanceMolecular Endocrinology, 1988
- Estrogenic Regulation of Growth and Polypeptide Growth Factor Secretion in Human Breast CarcinomaEndocrine Reviews, 1987
- Cell Proliferation of Estrogen-Sensitive Cells: The Case for Negative Control*Endocrine Reviews, 1987
- Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cellsCell, 1987
- A simple, rapid, and sensitive DNA assay procedureAnalytical Biochemistry, 1980